This is very interesting because one of the key risks with LTR Pharma is that they have not yet secured a patent, I believe? (Please correct me if I am wrong)
I wonder what this partnership means for securing a patent?
Would the patent application be amended to include Aptar's novel technology?
If so would Aptar throw resources at helping secure a patent?
I like this announcement.
This is very interesting because one of the key risks with LTR...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
28.0¢ |
Change
0.005(1.82%) |
Mkt cap ! $31.34M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.3¢ | 27.5¢ | $86.44K | 308.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 77717 | 28.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.5¢ | 50000 | 2 |
View Market Depth
| Last trade - 15.59pm 19/06/2025 (20 minute delay) ? |
| LTP (ASX) Chart |